Madison Avenue Partners, LP

13F Holdings History for Sage Therapeutics, Inc. - Common Stock, par value $0.0001 per share (the "Common Stock") (SAGE)

Symbol: SAGE
Investment type: Equity / Common Stock, par value $0.0001 per share (the "Common Stock")
Latest Disclosed Ownership: 6.08M shares
Security Ownership: 9.7%

Shares, Excluding Options vs Price

Value, Excluding Options

Madison Avenue Partners LP ownership in Sage Therapeutics, Inc. Common Stock, par value $0.0001 per share (the "Common Stock") (SAGE)

2025-08-14 - Madison Avenue Partners LP has filed an SCHEDULE 13G/A form with the Securities and Exchange Commission (SEC) disclosing ownership of 6.08M shares of Sage Therapeutics, Inc. Common Stock, par value $0.0001 per share (the "Common Stock") (SAGE). This represents 9.7% percent ownership of the company. In their previous filing dated 2025-04-01, Madison Avenue Partners, LP had reported owning 4.92M shares, indicating an increase of 23.5% percent.

Reporting Name	Ownership %	Change	Value $	Shares owned	Change	Activity %	Price	Form	Report date	Filed at
Madison Avenue Partners LP	9.7%	+21.3%	$52.7M	6.08M	+1,156,302	+23.5%	$8.68	13G/A	6/30/2025	14 Aug 2025 09:22:49
Madison Avenue International LP	8%		$34M	4.92M			$6.91	13G	3/25/2025	1 Apr 2025 17:35:13

Holdings date	Option	Weight	Change	Value $	Shares	Change	Activity %	Price	All Holders
6/30/2025		3.7%	+0.97%	$55.4M	6.08M	+1,599,267	+35.7%	$9.12	Q2 2025
3/31/2025		3.02%	+3.02%	$35.6M	4.48M	+4,477,798	NEW	$7.95	Q1 2025

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.